TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ).
Zylox-Tonbridge Medical Technology Co., Ltd. has announced an update regarding its final dividend for the year ended December 31, 2024. The dividend is set at RMB 0.1 per share, with a payment in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.089909. The ex-dividend date is June 4, 2025, and the payment date is June 27, 2025. The company will withhold a 10% tax for non-resident enterprise shareholders and a 20% tax for domestic individual shareholders, reflecting its compliance with tax regulations.
The most recent analyst rating on (HK:2190) stock is a Buy with a HK$18.60 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. operates in the medical technology industry, focusing on the development and production of medical devices. The company is known for its innovative solutions and products that cater to various medical needs, enhancing healthcare delivery.
Average Trading Volume: 817,950
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.16B
Learn more about 2190 stock on TipRanks’ Stock Analysis page.